Publications by authors named "Jessica Faletti"

Claim this Profile
C
Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].
Sara Taranto, Jessica Faletti, Mariangela Tamburello, Roberto Ronca, Giulia Garattini

Biomed Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma.
Sara Taranto, Jessica Faletti, Mariangela Tamburello, Roberto Ronca, Giulia Garattini

Biomed Pharmacother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.
Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli, Jessica Faletti, Davide Capoferri

J Exp Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity.
Sara Taranto, Riccardo Castelli, Giuseppe Marseglia, Laura Scalvini, Federica Vacondio, Jessica Faletti

Pharmacol Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer.
Arianna Giacomini, Marta Turati, Elisabetta Grillo, Sara Rezzola, Gaia Cristina Ghedini, Jessica Faletti

Exp Hematol Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten Years of CRISPRing Cancers In Vitro.
Davide Capoferri, Serena Filiberti, Jessica Faletti, Camilla Tavani, Roberto Ronca

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis